Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.
about
Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors.Impact of Increased Astrocyte Expression of IL-6, CCL2 or CXCL10 in Transgenic Mice on Hippocampal Synaptic FunctionCharacterizing autism spectrum disorders by key biochemical pathways.Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum DisordersThe neurology of mTORChannelopathy pathogenesis in autism spectrum disordersDendritic spine dysgenesis in autism related disordersIntraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3.Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in miceEarly hyperactivity and precocious maturation of corticostriatal circuits in Shank3B(-/-) micemTOR and MAPK: from localized translation control to epilepsyCommon mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disordersActivity-dependent adaptations in inhibitory axonsMEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders.Tricornered Kinase Regulates Synapse Development by Regulating the Levels of Wiskott-Aldrich Syndrome ProteinIn vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndromeInvestigating mechanisms underlying neurodevelopmental phenotypes of autistic and intellectual disability disorders: a perspective.Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.Inhibition of microRNA 128 promotes excitability of cultured cortical neuronal networks.Decrease of SYNGAP1 in GABAergic cells impairs inhibitory synapse connectivity, synaptic inhibition and cognitive function.mTORC1 Is a Local, Postsynaptic Voltage Sensor Regulated by Positive and Negative Feedback Pathways.Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons.Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.Activation of mGluR2/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism.In vivo evidence for mTORC2-mediated actin cytoskeleton rearrangement in neuronsSemaphorin 5A inhibits synaptogenesis in early postnatal- and adult-born hippocampal dentate granule cells.mTOR signaling in epilepsy: insights from malformations of cortical developmentTuberous Sclerosis: A New Frontier in Targeted Treatment of AutismThe Stress-Induced Atf3-Gelsolin Cascade Underlies Dendritic Spine Deficits in Neuronal Models of Tuberous Sclerosis Complex.REDD2-mediated inhibition of mTOR promotes dendrite retraction induced by axonal injuryElevated CaMKIIα and Hyperphosphorylation of Homer Mediate Circuit Dysfunction in a Fragile X Syndrome Mouse Model.Translational control in synaptic plasticity and cognitive dysfunctionAnalysis of Proteins That Rapidly Change Upon Mechanistic/Mammalian Target of Rapamycin Complex 1 (mTORC1) Repression Identifies Parkinson Protein 7 (PARK7) as a Novel Protein Aberrantly Expressed in Tuberous Sclerosis Complex (TSC)Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference.An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical developmentHepatocyte Growth Factor Modulates MET Receptor Tyrosine Kinase and β-Catenin Functional Interactions to Enhance Synapse Formation.Neuronal autophagy and neurodevelopmental disorders.A novel Hap1-Tsc1 interaction regulates neuronal mTORC1 signaling and morphogenesis in the brain.mTOR, a Potential Target to Treat Autism Spectrum Disorder.The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.
P2860
Q26269833-F8552044-2B56-4B75-9626-B46522C733B2Q26744301-57B423EF-2AC3-4811-A65A-4D985815A1EDQ26781645-1D0F6962-F4B3-4572-961A-647AD3129746Q26796321-F1C29E66-6870-49AE-A871-63BF945E5D61Q26824286-BB3E254E-FD15-4DF8-8097-A0C3D733AF7CQ26864726-0500CB21-682D-451C-BCF9-378CF246AAD2Q26995242-728E2A38-E364-4AF3-8B03-54CF972C11C9Q27307787-DDAD2641-5B72-43DB-85DB-2FE4F0BC2925Q27310784-3B2DE240-84C5-4383-9E95-437D5B6AFB18Q27311527-0CD7A069-2E12-47F2-84D1-B16CE47B7FB3Q28076827-85EB0545-A0E7-4DE6-B432-6532B09903A1Q28086869-BF40694D-F0C2-4B09-B3EE-61E2610AB975Q28661510-6BF500CC-E7B4-475F-A291-14191BC0CDAEQ30370553-FF307A98-D053-4D18-BF71-3D72A98DCEF8Q30370750-F9E87D81-BECA-46EA-8472-A0B8DA2BFB45Q30406616-8011EF51-5E27-44C7-8213-769C103831B2Q30447502-5095B337-AD31-40EA-B74B-B3C227E5E7AEQ30586288-8452E883-EE93-4D22-BD9C-E67841E23CC3Q30818838-B220DB3E-60E8-4630-9184-EF51C7DECBA5Q30828334-41F517F1-1214-47C0-9A96-998EE32D1982Q33736580-7565E329-ACB9-469A-9A96-A407004DB889Q33740090-96E566BD-F6A2-403A-91F2-665BCFB01259Q33763506-25C88414-9352-4DEB-97BF-A0F9D30FCFA2Q33764854-EC2B7FA4-61EA-4465-8970-BE52560405C7Q34362461-0F3CE886-C793-4C0E-AC08-3C8797767BF9Q34538801-F0F2809C-9D58-4E99-95C9-183FF73CA227Q35245211-BDBA895A-7E93-471B-82CE-1F3792F9AAD4Q35811772-FB2F3331-486C-434A-BD2B-F5F6AC205E56Q35897734-42E52582-F00F-4403-A13E-9AF822E6A4A0Q36067739-1DE6641E-6D16-4C7D-AD3E-82F5EB0FA493Q36387172-207582F1-C913-4EC3-A70B-11F5E7E07329Q36487154-F31796DC-3A49-45BA-9CE1-CCB4AC450219Q36539459-35CABC80-A08B-4D83-BF49-D9298ADDD8C6Q37038637-0E526917-AA2D-4218-863C-4BBC6F1689E2Q37114126-BD0A9DE2-A43D-409E-B110-1EFB43EFF2ECQ37213011-7E2BB6E0-F0E7-4C13-B9EE-4646C01E7CABQ37251865-375B9E65-A36D-46F6-B03F-ED4B385ACCFEQ37309501-6DC8EBE9-E317-40B6-8FC9-23AEEF2EB880Q37350523-357F5E7F-68DE-4D67-A346-BF3626F91221Q37559828-A7160735-1328-4483-BCDB-C8C584D91F47
P2860
Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Excitatory/inhibitory synaptic ...... models of tuberous sclerosis.
@ast
Excitatory/inhibitory synaptic ...... models of tuberous sclerosis.
@en
type
label
Excitatory/inhibitory synaptic ...... models of tuberous sclerosis.
@ast
Excitatory/inhibitory synaptic ...... models of tuberous sclerosis.
@en
prefLabel
Excitatory/inhibitory synaptic ...... models of tuberous sclerosis.
@ast
Excitatory/inhibitory synaptic ...... models of tuberous sclerosis.
@en
P2093
P2860
P1433
P1476
Excitatory/inhibitory synaptic ...... models of tuberous sclerosis.
@en
P2093
Bernardo L Sabatini
Caroline A Johnson
Cassandra L Denefrio
Helen S Bateup
Jessica L Saulnier
Karl Kornacker
P2860
P304
P356
10.1016/J.NEURON.2013.03.017
P407
P577
2013-05-01T00:00:00Z